FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Brendan ...
Tag: Drug
The weight-loss drug boom has become one of the internet’s biggest scams
A production line of Wegovy injection pens for the Asian market at the Novo Nordisk A/S pharmaceutical manufacturing facility in ...
Biden highlights drug price reductions with New Hampshire visit
President Biden visits Democratic Party Headquarters in Manchester, NH President Biden visits Democratic Party Headquarters in Manchester, NH 00:33 Concord, ...
Medicare drug plans are getting better next year. Some will also cost more.
When Pam McClure learned she'd save nearly $4,000 on her prescription drugs next year, she said, "it sounded too good ...
Drug costs, abortion, Obamacare: How Trump and Harris could change U.S. health care
President Donald Trump talks to the press outside the White House, July 19, 2019, left, and Democratic presidential nominee and ...
CVS, UnitedHealth, Cigna say FTC should take Lina Khan and two commissioners off drug middlemen case
FTC Chairwoman Lina Khan testifies during the House Appropriations Subcommittee on Financial Services and General Government hearing titled "Fiscal Year ...
Old newspaper dispensers deliver Narcan opioid overdose reversal drug instead of news
"With one push, you could save a life." Framingham offers free Narcan training "With one push, you could save a ...
FDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades
Bristol Myers Squibb's Cobenfy drugCourtesy: Bristol Myers SquibbThe Food and Drug Administration on Thursday approved Bristol Myers Squibb's highly anticipated ...
FTC sues drug middlemen for allegedly inflating insulin prices
Lina Khan, Chair of the Federal Trade Commission (FTC), testifies before the House Appropriations Subcommittee at the Rayburn House Office ...
Drug middlemen illegally drive up the cost of insulin, FTC says
Federal regulators are accusing the country's three largest pharmacy benefit managers of illegally driving up the cost of insulin in ...
